Calamos Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$831K Buy
+4,387
New +$651K ﹤0.01% 778
2023
Q4
Sell
-14,274
Closed -$2.33M 924
2023
Q3
$2.33M Sell
14,274
-4
-0% -$704 0.01% 603
2023
Q2
$2.62M Buy
14,278
+8,746
+158% +$1.26M 0.01% 636
2023
Q1
$737K Buy
+5,532
New +$650K ﹤0.01% 832

Other funds holding ACLS

Calamos Advisors's ACLS Position: Q2 2026 in Review

Calamos Advisors opened a new position in Axcelis (ACLS) in Q2 2026: 4,387 shares worth $831K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings. This is a return to the name: Calamos Advisors previously reported a position in ACLS as recently as Q3 2023.

Calamos Advisors first reported a position in ACLS in Q1 2023 and has held it in 4 quarters since. The position peaked at $2.62M in Q2 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Calamos Advisors held 4,387 shares of Axcelis worth $831K as of Q2 2026.
  • Axcelis was a new Calamos Advisors position in Q2 2026.
  • Axcelis made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #778 holding.
  • Calamos Advisors first reported a position in Axcelis in Q1 2023 and has held it in 4 quarters since.
  • Calamos Advisors's Axcelis position peaked at $2.62M in Q2 2023.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.